BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 27593914)

  • 1. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
    Rao PV; Pattabiraman PP; Kopczynski C
    Exp Eye Res; 2017 May; 158():23-32. PubMed ID: 27593914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated intraocular pressure induces Rho GTPase mediated contractile signaling in the trabecular meshwork.
    Pattabiraman PP; Inoue T; Rao PV
    Exp Eye Res; 2015 Jul; 136():29-33. PubMed ID: 25956210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.
    Rao PV
    J Ocul Pharmacol Ther; 2014; 30(2-3):181-90. PubMed ID: 24283588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.
    Honjo M; Tanihara H
    Jpn J Ophthalmol; 2018 Mar; 62(2):109-126. PubMed ID: 29445943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment.
    Braunger BM; Fuchshofer R; Tamm ER
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):173-81. PubMed ID: 25957840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
    Rao PV; Deng PF; Kumar J; Epstein DL
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired TRPV4-eNOS signaling in trabecular meshwork elevates intraocular pressure in glaucoma.
    Patel PD; Chen YL; Kasetti RB; Maddineni P; Mayhew W; Millar JC; Ellis DZ; Sonkusare SK; Zode GS
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33853948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylate cyclase activators, cell volume changes and IOP reduction.
    Ellis DZ
    Cell Physiol Biochem; 2011; 28(6):1145-54. PubMed ID: 22179003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-associated kinase inhibitors: a novel glaucoma therapy.
    Inoue T; Tanihara H
    Prog Retin Eye Res; 2013 Nov; 37():1-12. PubMed ID: 23770081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trabecular meshwork as a new target for the treatment of glaucoma.
    Ferrer E
    Drug News Perspect; 2006 Apr; 19(3):151-8. PubMed ID: 16804567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel therapeutic targets for reduction of intraocular pressure in primary open angle glaucoma].
    Mao WM; Liu Y; Wordinger YH; Clark AF; Pang IH
    Zhonghua Yan Ke Za Zhi; 2016 Jun; 52(6):471-5. PubMed ID: 27373575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.
    O'Callaghan J; Cassidy PS; Humphries P
    Expert Opin Ther Targets; 2017 Nov; 21(11):1037-1050. PubMed ID: 28952395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular Pressure and the Mechanisms Involved in Resistance of the Aqueous Humor Flow in the Trabecular Meshwork Outflow Pathways.
    Tamm ER; Braunger BM; Fuchshofer R
    Prog Mol Biol Transl Sci; 2015; 134():301-14. PubMed ID: 26310162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho kinase inhibitors for glaucoma treatment - Review.
    Germano RA; Finzi S; Challa P; Susanna Junior R
    Arq Bras Oftalmol; 2015; 78(6):388-91. PubMed ID: 26677046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow.
    Rao PV; Deng P; Maddala R; Epstein DL; Li CY; Shimokawa H
    Mol Vis; 2005 Apr; 11():288-97. PubMed ID: 15889013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TET-dependent GDF7 hypomethylation impairs aqueous humor outflow and serves as a potential therapeutic target in glaucoma.
    Wan P; Long E; Li Z; Zhu Y; Su W; Zhuo Y
    Mol Ther; 2021 Apr; 29(4):1639-1657. PubMed ID: 33388417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK5 inhibitor acts on trabecular meshwork cell and reduces intraocular pressure.
    Aoshima K; Inagaki S; Takagi Y; Nakamura S; Hara H; Shimazawa M
    Exp Eye Res; 2023 Feb; 227():109382. PubMed ID: 36634838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The progress of aqueous humor outflow pathway in open-angle glaucoma].
    An L; Ji J
    Zhonghua Yan Ke Za Zhi; 2011 Oct; 47(10):953-6. PubMed ID: 22321508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.
    Babizhayev MA
    Fundam Clin Pharmacol; 2012 Feb; 26(1):86-117. PubMed ID: 21883446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous outflow regulation: Optical coherence tomography implicates pressure-dependent tissue motion.
    Xin C; Wang RK; Song S; Shen T; Wen J; Martin E; Jiang Y; Padilla S; Johnstone M
    Exp Eye Res; 2017 May; 158():171-186. PubMed ID: 27302601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.